The Second Circuit upheld the insider trading conviction of Robert Schulman, a former patent attorney at Hunton & Williams, convicted in 2017 for tipping his investment adviser, Tibor Klein, to Pfizer’s planned acquisition of King Pharmaceuticals in 2010. Schulman appealed a decision rejecting his motion to vacate his conviction on grounds of insufficient evidence. In affirming that decision, the Second Circuit concluded that the jury was not required to credit Schulman’s testimony that he intended only to brag about his knowledge of the merger to a friend.
January 10, 2019
Second Circuit upholds insider trading conviction of former lawyer
Related by Topic
New Post
Russian hacker sentenced to 9 years in prison for role in insider trading scheme
September 13, 2023
News Alert
Two defendants plead guilty for their roles in an insider trading scheme
September 8, 2023
News Alert
Visiting attorney from Brazil charged in the US with insider trading
August 28, 2023
News Alert